Skip to main content
. 2021 Jan 31;10(1):1863631. doi: 10.1080/2162402X.2020.1863631

Table 3.

Patients alive at last follow-up

Study subject # Radiation site Stratum Dose Best distant response (RECIST) Time to progression from RT (months) Therapy at progression Status at last f/u Time from RT to last f/u or death (months)
1 Lung 1 8 Gy x 2 SD 9.8 SBRT to new lung lesion; resection of brain met; pembro Alive; SD on pembro 97.4
8 Lung 1 8 Gy x 2 PD 5.4 pembro Alive; SD on pembro 36.7
10 Liver 2 6 Gy x 2 PR N/A N/A NED 88.7
16 Lung 1 8 Gy x 3 PR 12.2 Gamma Knife and resection of brain mets; then pembro Stable disease on pembro 82.6
17 Axillary nodal mass 2 6 Gy x 3 PD 3.3 pembro; then progressed in breast; mastectomy; placed on B-raf inhibitors Alive; SD on B-Raf inhibitors 82.2
20 Lung 1 8 Gy x 3 SD 7.6 pembro SD on pembro 24.9
22 Lung 1 8 Gy x 3 PR 12.3 pembro Stable disease on pembro 57.6